scholarly journals ДІЄТИЧНА ДОБАВКА ІМУНОТРОПНОЇ ДІЇ НА ОСНОВІ ПРОДУКТІВ ДЕСТРУКЦІЇ ПРОБІОТИЧНИХ БАКТЕРІАЛЬНИХ КУЛЬТУР

2018 ◽  
Vol 82 (1) ◽  
Author(s):  
Антоніна Іванівна Капустян ◽  
Наталля Кирилівна Черно

У роботі розглянуто можливість отримання імунотропної дієтичної добавки на основі низькомолекулярних продуктів деградації пептидогліканів клітинних стінок пробіотичних бактерій. Встановлено раціональні режими автолізу біомаси як первинного етапу деструкції пептидогліканів бактеріальних клітинних стінок. Показано, що найбільш інтенсивний лізис клітин відбувається при експозиції культуральної рідини при 90°C протягом 15 хв після 8-ї години культивування, про що свідчить максимальне накопичення амінокислот у реакційному середовищі (1,8 мг/см3). Проведено оптимізацію процесу деструкції пептидогліканів бактеріальних клітин, які піддавали лізису, ферментним препаратом панкреатином. Ефективність ферментолізу визначали за накопиченням імунотропних низькомолекулярних пептидів залежно від концентрації ферменту (СЕ), субстрату (СS) в реакційній суміші та тривалості процесу (τ). Встановлено, що раціональний режим ферментолізу, який забезпечує максимальне накопичення низькомолекулярних пептидів (0,569 мг/см3, досягається за наступних значень факторів: СЕ=12,5 мг/см3, СS=70,0 мг/см3, τ=245,6 хв. Зразок низькомолекулярних пептидів, отриманий за раціональних режимів деструкції, досліджено методом ІЧ-спектроскопії. Встановлено, що у його ІЧ-спектрі присутні смуги поглинання, які відповідають коливанням аміногруп, пептидних зв’язків, піранозної форми глюкози, залишки якої входять до складу мурамової кислоти, та N-ацетилглюкозаміну пептидоглікану. Приведено загальну схему, що ілюструє послідовність процесів виробництва імунотропної дієтичної добавки .У дослідах на щурах встановлено ефективну дозу отриманої дієтичної добавки –0,06 мг/кг маси тіла.  The possibility of obtaining an immunotropic dietary supplement based on low molecular weight degradation products of cell wals peptidoglycans of lactic and bifidobacteria composition has been considered. Rational regimes of autolysis of biomass as the primary stage of degradation of peptidoglycans of bacterial cell walls have been established. It was shown that the most intensive lysis of cells takes place when the culture liquid is treated at a temperature of 90 °C for the 8th hour of cultivation, as indicated by the maximum accumulation of amino acids in the reaction medium (1.8 mg/cm3). Optimization of the destruction process of bacterial cell peptidoglycans exposed to lysis, by enzyme preparation with pancreatin, was carried out by the mathematical planning method of the multifactorial experiment. The effectiveness of enzymatic hydrolysis was determined by the accumulation of immunotropic low molecular weight peptides, depending on the concentration of the enzyme (CE), the substrate (CS) in the reaction mixture and the duration of the process (τ). The rational value of the factors CE, CS and τ that provide the maximum concentration of low molecular weight peptides (0.569 mg/cm3) in the enzymatic hydroltsate are CE=12.5 mg/cm3, Cs=70.0 mg/cm3, τ=245.6 min. A sample of low molecular weight peptides obtained from rational degradation regimes was investigated using the IR spectroscopy method. It has been established that in its spectrum absorption bands corresponding to fluctuations of amino groups, peptide bonds are presentred, which, in fact, take place in the structure of peptides. Fluctuations of the pyranose glucose form, which is included in the muramic acid and N-acetylglucosamine of peptidoglycan, have also been observed. The general scheme of the sequence of production processes of an immunotropic dietary supplement has been given. In animal experiments, it has been established that this additive, in accordance with the classification of chemicals substances to the degree of danger, belongs to class 4 (low-toxic substances). The effective dose of the obtaned dietary supplement is 0.06 mg/kg body weight.

Holzforschung ◽  
2002 ◽  
Vol 56 (2) ◽  
pp. 199-208 ◽  
Author(s):  
Thomas Rosenau ◽  
Antje Potthast ◽  
Andreas Hofinger ◽  
Herbert Sixta ◽  
Paul Kosma

Summary Polonowski type degradation reactions are a major reason for the frequently observed instability of solutions of cellulose in N-methylmorpholine-N-oxide monohydrate (NMMO, 1). The degradation is induced by degradation products of cellulose and NMMO generated in situ in the Lyocell system. The presence of both an amine component, such as morpholine or N-methylmorpholine, and an acid component is required for the decomposition process to proceed. The latter might be a low-molecular-weight compound, such as formic acid, acetic acid or gluconic acid, or also a high-molecular-weight acid, such as polyglucuronic acid or ion exchange resin.


1987 ◽  
Author(s):  
S Vannucchi ◽  
F Pasquali ◽  
P Bianchi-ni ◽  
M Ruggiero

In this study we show that bovineadrenal capillary endothelial cells(BACE) contain heparin (HP); this HP has been found associated with the cell surface (i.e; trypsin-removable^and intracellularly. How-ever, experiments with [ sjsodium sulfate labelling, demonstrate that BACE cells donot synthesize HP de novo, but they uptake it from serum. We have studied binding, uptake, and metabolism odifferent molecular weight-HPs: 13 Kd-HP from bovine source, 14 Kd-HP from porcine source, 4.5 Kd, and 2.5-HP fragments. Comparison among different HPs, was carried out by calculating the IC from competition curves for [3HJ- HP. Binding of labelled-HP to BACE cells was specificand saturable. Dextran sulfate and glycosaminoglycans did not compete for binding; only heparan sulfate showed some competition. Binding of different HPs was strictly dependent on their molecular weight; 2.5 Kd- HP was unable to bind to cells, although sulfation degree of this fragment and of unfractionated HP was almost identical. Therefore, we assume that a specific oligosaccharide sequence could be responsible for HP binding to BACE cells; this hypothetical "binding sequence" could then be lost in very low molecular weight-HP fragments. BACE cells are also able to internalize HP, and they release its low molecular weight degradation products into culture medium. Thus we suggest that endothelial cells might represent a site for the metabolism of endogenous and exogenous HP in vivo.


2018 ◽  
Vol 1 (1) ◽  
pp. 47 ◽  
Author(s):  
Antonina Ivanovna Kapustian ◽  
Natalia Cherno ◽  
Alexei Kovalenko ◽  
Kristina Naumenko ◽  
Igor Kushnir

Lactic acid bacteria (LAB) and bifidobacteria (BB) are unique substances that have a lot of biological and physiological effects. Structural components of LAB and BB – peptidoglycans, compounds of the muramylpeptide series, teichoic acids – have powerful immunological properties. Metabolites of LAB and BB – organic acids, hydrogen peroxide, bacteriocins, etc. – provide antagonistic activity, have an indirect impact on the immune system, reducing the antigenic load caused by pathogenic microorganisms. The expediency of peptidoglycans degradation of LAB and BB cell walls is substantiated. Low molecular weight products of the degradation can easily be absorbed and enter into biochemical processes, accelerating the expected functional-physiological effect. To obtain low-molecular products of peptidoglycans degradation, a combination of LAB and BB was used. The combination of LAB and BB is the sum of the test cultures of Lactobacillus acidophilus, Lactobacillus delbrueckii subsp. Bulgaricus, Bifidobacterium bifidum, Lactococcus cremoris, Streptococcus termophilus. Destruction of peptidoglycans of bacterial cell walls was carried out using a combination of disintegrating factors. The efficiency of destruction was determined by the accumulation of low molecular weight peptides (with molecular weight up to 1500 Da), amino acids and soluble protein in the disintegrate. It has been established that the highest accumulation of low molecular weight degradation products occurs when using autolysis followed by enzymatic hydrolysis during 180 min with the ratio of the enzyme : substrate 1 : 100. At the same time ≈ 53% of protein substances pass from insoluble to soluble state. The molecular weight of the obtained products is determined by the gel chromatography method. The qualitative and quantitative content of organic acids, amino acids and vitamins of group В in the hydrolysis products composition was investigated. It was shown that the obtained product possesses high biological effect in the experiment on animals.


1974 ◽  
Vol 32 (02/03) ◽  
pp. 350-355
Author(s):  
Akira Takaki ◽  
Tsuyoshi Yamaguchi ◽  
Keiichi Ohsato

SummarySome biological properties of a synthetic peptide based on an anticoagulant peptide obtained from fibrinogen degradation products by the action of plasmin are reported. This peptide produced smooth muscle contraction without the presence of bradykinin. The contraction caused by this peptide was not modified by atropin (10-6 g/ml), hyoscine (10-6 g/ml) and tetrodotoxin (2xl0-7 g/ml). A hypotensive effect was observed following the intravenous injection of the peptide into an anesthetized rat indicating that this peptide has an action similar to that of bradykinin though less potent.


1992 ◽  
Vol 68 (03) ◽  
pp. 357-363 ◽  
Author(s):  
Roberto Lorenzet ◽  
Joan H Sobel ◽  
Alessandra Bini ◽  
Larry D Witte

SummaryCultured porcine aortic endothelial cells (PAEC) constitutively produce and secrete in their culture medium mitogens collectively called endothelial cell-derived growth factors (EDGFs). Incubation of PAEC with fibrinogen-degradation products (FDPs) obtained by plasmin digestion of highly purified fibrinogen caused an increased release of EDGFs, as assessed by [3H]-thymidine incorporation in 3T3 mouse fibroblasts. The effect was time-dependent and correlated with the degree of fibrinogenolysis. It was accompanied by elongation of the cells. Neither increase in EDGFs release nor cell damage was observed when non-degraded fibrinogen was incubated with endothelial cells. Low molecular weight fibrinogen degradation products (LMWFDPs) (M r ≤ 10,000), and the higher molecular weight fibrinogen fragments D and E were tested under the same conditions. Only the LMWFDPs caused elongation and damage to PAEC and a marked stimulation (up to 12 fold) of EDGFs release. A low density growth assay revealed that the released EDGFs were mitogenically active on the same PAEC. The activity of the released EDGFs was time and dose dependent on both 3T3 fibroblasts and PAEC, indicating that LMWFDPs caused enhanced release of EDGFs that can act in paracrine and autocrine fashion. This study suggests an additional role for fibrinogenolysis contributing to wound healing, and possibly to atherosclerosis.


1979 ◽  
Author(s):  
B. Gerdin ◽  
T. Saldeen ◽  
H. Sandler ◽  
G. Sedin

In posttraumatic pulmonary insufficiency microembolism of fibrin to the lungs and inhibited fibrinolysis have been given key-roles and the term "the delayed microembolism syndrome" has been designated to those cases. The pathogenetic mechanisms involved are only to a limited extent known. Those were investigated in a rat model. Fibrinolysis was inhibited with AMCA and intravascular coagulation induced by a 5-min injection of thrombin, 500 NIH/kg b.w.. Within 5 min a profound consumption of fibrinogen occurred and 125-la- belled fibrin was embolized to the lungs. At that time the alveolar circulation was decreased, vasoconstriction and platelet-red cell aggragates appeared as seen by in vivo microscopy and arterial P02 was diminished irrespective of fibrinolysis. After restitution for 1 h a progressive pulmonary insufficiency with P02 decrease and PC02 retention occurred. Trasylol® did not influence on pulmonary damage. Converting enzyme activity was not diminished. A retention of fibrin degradation products (fdp) occurred in the lungs and infusion of low molecular weight fdp aggravated pulmonary oedema. Lung mast cells were partly degranulated and mepyramine maleate slightly counteracted pulmonary oedema. It is concluded that release of vasoactive low molecular weight fdp probably plays a causal role in oedema formation; probably in part by releasing histamine from lung mast cells.


1977 ◽  
Author(s):  
L.A. Moroz

Despite evidence implicating PMN in fibrinolysis, the enzymes involved are incompletely characterized.PMN were prepared from normal blood by dextran sedimentation and fibrinolytic activity assayed by l25I-fibrin solid phase assay (Blood 46:543, 1975). More than 80% of activity was associated with intact PMN, was stimulated by Na salicylate (+65%, 20 mg/100 ml) and inhibited by α1-anti-trypsin (α1AT, -48%, 2 × 10-6 M). Similar activity was found in a PMN membrane fraction prepared by homogenization, differential centrifugation and Sepharose 4B gel filtration, from which fraction it was released by freeze-thawing and/or IM KCl treatment. Soluble enzyme activity was inhibited by of α1AT (-80%, 10-6 M), PMSF (-98%, 10-3 M), FeCl3 and ZnCl3 (-100%, 10-2 M), vitamin E(-38%, 10-4 M) and trypan blue (-40%, 10-3 M), but not by EACA (10-2 M), tranexamic acid (10-2 M), TLCK (10-3 M) or TPCK (10-3 M). This activity had an alkaline proteinase pH-activity profile, was localized to a single cationic protein band on acid Polyacrylamide disc gel electrophoresis, with pl of 8.6-8.7 by isoelectric focussing, and eluted between lysozyme and myoglobin on Bio-Gel P-10. On Bio-Gel A 0.5m and P-10, 125I-fibrin degradation products eluted after myoglobin. These findings indicate the presence in PMN of a low molecular weight, membrane-associated fibrinolytic enzyme of alkaline proteinase and serine active site type.


Sign in / Sign up

Export Citation Format

Share Document